loader

World Tenders & Procurement Opportunities

Search
Advanced Search

639571- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-29 - Omalizumab

World Biggest Tenders Source

This tender with title 639571- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-29 - Omalizumab has been published on Bidding Source portal dated 01 Oct 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

639571- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-29 - Omalizumab
Invitation for Bids
639571
Germany
1 Oct 2025
31 Oct 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

634564- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the aforementioned active ingredients with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 637367- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-24 - Ranibizumab Germany 635720-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Enoxaparin (exclusively IFE 100 mg N2), ATC B01AB05 for the period 01.04.2025 - 31.03.2027 Germany 635462-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient dexamethasone (excluding implants), ATC S01BA01 for the period 01.01.2025 - 31.12.2026 Germany 634636-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient mesalazine, ATC A07EC02 for the period 01.02.2024 - 31.01.2026 Germany 634017-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Timolol + Brinzolamide, ATC S01ED67 for the period 01.11.2024 - 31.10.2026 Germany 633126-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Bimatoprost + Timolol (exclusively EDO), ATC S01ED62 for the period 01.08.2024 - 31.07.2026 Germany 628921- Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-30 - Afatinib Germany 627257- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 1 November 2025 to 31 October 2027 Germany 627406-Awarded - Germany – Pharmaceutical products – 1/DLII6/PM031 diverse Arzneimittel Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans